Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Maintenance Therapy in Bone Sarcoma
NCT04758000Phase 2Recruiting
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Mar 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in osteosarcoma (OS), Ewing sarcoma, sponsored by Istituto Ortopedico Rizzoli. Started Mar 2021; status: recruiting.
02
Drugs
metformin
03
Conditions
osteosarcoma (OS)Ewing sarcoma
Beyond the preview
Go deeper on NCT04758000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04758000.